V. Bláha

2.6k total citations
154 papers, 1.5k citations indexed

About

V. Bláha is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, V. Bláha has authored 154 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Surgery, 23 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in V. Bláha's work include Lipoproteins and Cardiovascular Health (50 papers), Cholesterol and Lipid Metabolism (16 papers) and Cancer, Lipids, and Metabolism (16 papers). V. Bláha is often cited by papers focused on Lipoproteins and Cardiovascular Health (50 papers), Cholesterol and Lipid Metabolism (16 papers) and Cancer, Lipids, and Metabolism (16 papers). V. Bláha collaborates with scholars based in Czechia, United States and Germany. V. Bláha's co-authors include Z Zadák, M. Bláha, Dagmar Solichová, Michael M. Meguid, L. Sobótka, Alessandro Laviano, Jiake Chai, J Malý, Albert Oler and Zhong‐Jin Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

V. Bláha

130 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Bláha Czechia 22 411 249 206 200 193 154 1.5k
Rémy Couderc France 26 450 1.1× 356 1.4× 177 0.9× 79 0.4× 389 2.0× 63 1.9k
Xuemei Liu China 24 445 1.1× 616 2.5× 136 0.7× 91 0.5× 168 0.9× 143 1.8k
Julie Martin Canada 25 345 0.8× 339 1.4× 206 1.0× 93 0.5× 505 2.6× 82 1.8k
Jie Yu China 26 327 0.8× 738 3.0× 150 0.7× 208 1.0× 315 1.6× 141 2.3k
Björn Anderstam Sweden 34 396 1.0× 530 2.1× 277 1.3× 104 0.5× 602 3.1× 87 2.8k
Cecilia Nilsson Sweden 21 164 0.4× 226 0.9× 323 1.6× 103 0.5× 274 1.4× 38 1.5k
Jeffrey W. Miller United States 16 206 0.5× 143 0.6× 269 1.3× 270 1.4× 179 0.9× 29 1.2k
Tong‐Yuan Tai Taiwan 18 157 0.4× 449 1.8× 225 1.1× 83 0.4× 234 1.2× 24 1.9k
Yanxin Wang China 21 356 0.9× 351 1.4× 134 0.7× 88 0.4× 259 1.3× 57 2.1k
Francesco Martino Italy 28 377 0.9× 298 1.2× 336 1.6× 70 0.3× 394 2.0× 112 2.1k

Countries citing papers authored by V. Bláha

Since Specialization
Citations

This map shows the geographic impact of V. Bláha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Bláha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Bláha more than expected).

Fields of papers citing papers by V. Bláha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Bláha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Bláha. The network helps show where V. Bláha may publish in the future.

Co-authorship network of co-authors of V. Bláha

This figure shows the co-authorship network connecting the top 25 collaborators of V. Bláha. A scholar is included among the top collaborators of V. Bláha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Bláha. V. Bláha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skořepa, Pavel, F Musil, Lenka Javorská, et al.. (2025). Coagulation in familial hypercholesterolemic patients: effect of current hypolipidemic treatment and anticoagulants. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(6). 7343–7352.
2.
Bláha, V., et al.. (2025). Comparison of taurolidine with 4% ethylenediaminetetraacetic acid on antimicrobial lock effectiveness: An experimental study. Journal of Parenteral and Enteral Nutrition. 49(3). 373–378.
3.
Bláha, V., Jana Rathouska, H Langrová, et al.. (2024). Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration. Scientific Reports. 14(1). 28902–28902. 1 indexed citations
4.
Máša, Vítězslav, et al.. (2023). Gas microturbine as a main source of energy for industrial laundry – feasibility study. Energy. 267. 126630–126630. 1 indexed citations
5.
Bláha, V., et al.. (2023). Rheopheresis in the Treatment of Age-Related Macular Degeneration. PubMed. 79(1). 8–24. 1 indexed citations
6.
Vráblík, Michal, Jan Piťha, V. Bláha, et al.. (2020). Stanovisko výboru České společnosti pro aterosklerózu k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2019. Cor et Vasa. 62(2). 185–197. 4 indexed citations
7.
Šmahelová, Alena, et al.. (2020). Metformin‑associated lactic acidosis. Vnitřní lékařství. 66(7). 438–442. 1 indexed citations
8.
Skořepa, Pavel, et al.. (2020). The Impact of Glucose-Based or Lipid-Based Total Parenteral Nutrition on the Free Fatty Acids Profile in Critically Ill Patients. Nutrients. 12(5). 1373–1373. 10 indexed citations
9.
Vráblík, Michal, Jan Piťha, V. Bláha, et al.. (2019). Stanovisko výboru České společnosti pro aterosklerózu k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2019. Vnitřní lékařství. 65(12). 743–754.
10.
11.
Soška, Vladimír, Michal Vráblík, V. Bláha, et al.. (2016). [PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated?Czech atherosclerosis society statement].. PubMed. 62(4). 329–33. 1 indexed citations
12.
Bláha, V., Josef Šťásek, Ctirad Andrýs, et al.. (2014). The Role of VEGF in the Diabetic Patients Undergoing Endovascular Therapy of Symptomatic Aortic Valve Stenosis. Physiological Research. 63(Suppl 3). S351–S359. 4 indexed citations
13.
Bláha, V.. (2014). Léčba hypercholesterolemie inhibitory PCSK9. Interní medicína pro praxi. 16(5). 179–183.
14.
Soška, Vladimír, H Vaverková, Michal Vráblík, et al.. (2013). Stanovisko výboru ČSAT k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2011. Interní medicína pro praxi. 15(10). 322–326.
15.
Bláha, M., Hana Vlčková, Lucie Nováková, et al.. (2010). Use of Ultra High Performance Liquid Chromatography‐Tandem Mass Spectrometry to Demonstrate Decreased Serum Statin Levels after Extracorporeal LDL‐Cholesterol Elimination. BioMed Research International. 2011(1). 912472–912472. 4 indexed citations
16.
Bláha, V., S Sulková, Marta Kalousová, et al.. (2009). Circulating fetuin-A predicts early mortality in chronic hemodialysis patients. Clinical Biochemistry. 42(10-11). 996–1000. 9 indexed citations
17.
Melichar, Bohuslav, Dagmar Solichová, M. Bláha, et al.. (2005). Urinary Neopterin and Microalbuminuria in Patients Treated by Low-density Lipoprotein Apheresis. Pteridines. 16(4). 174–183. 17 indexed citations
18.
Bláha, V., et al.. (1998). Ventromedial Nucleus of Hypothalamus is Related to the Development of Cancer-Induced Anorexia: In Vivo Microdialysis Study. Acta Medica (Hradec Kralove Czech Republic). 41(1). 3–11. 32 indexed citations
19.
Bláha, V., et al.. (1998). Hypocholesterolemic Effect of Pravastatin is Associated with Increased Content of Antioxidant Vitamin-E in Cholesterol Fractions. Acta Medica (Hradec Kralove Czech Republic). 41(2). 87–90. 7 indexed citations
20.
Bláha, V., Zhong‐Jin Yang, Michael M. Meguid, Jiake Chai, & Z Zadák. (1998). Systemic Nicotine Administration Suppresses Food Intake Via Reduced Meal Sizes in Both Male and Female Rats. Acta Medica (Hradec Kralove Czech Republic). 41(4). 167–173. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rémy Couderc Breakdown of academic impact, for papers by Xuemei Liu Breakdown of academic impact, for papers by Julie Martin Breakdown of academic impact, for papers by Jie Yu Breakdown of academic impact, for papers by Björn Anderstam Breakdown of academic impact, for papers by Cecilia Nilsson Breakdown of academic impact, for papers by Jeffrey W. Miller Breakdown of academic impact, for papers by Tong‐Yuan Tai Breakdown of academic impact, for papers by Yanxin Wang Breakdown of academic impact, for papers by Francesco Martino
Rankless by CCL
2026